Study finds Botox wears off quicker in GLP-1 patients In October 2025, a paper entitled Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indications , was published online
The trial results highlight the potential for patients taking GLP-1 drugs to lose too much weight, which could produce side effects and health problems that must be balanced against any benefits of weight loss, Dr
In some cases we utilize compound pharmacy formulations of GLP medications including Semaglutide and Tirzepatide when use of the traditional dosing strategy or brand name formulation is not appropriate
This drug maker has made a public announcement that it will be offering a generic form of semaglutide in 87 nations starting in 2026, with the initial markets being emerging nations like India, Brazil, Turkey, and Canada, pending patent expiration and regulatory approvals
The team explains how semaglutide works and addresses any questions or concerns you may have